Drug profile · INN
latanoprostene bunod
LATANOPROSTENE BUNOD
latanoprostene bunod (LATANOPROSTENE BUNOD) is a prostanoid fp receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — latanoprostene bunod
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
latanoprostene bunod (LATANOPROSTENE BUNOD) is a prostanoid fp receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid FP receptor agonist
Primary target: Prostaglandin F2-alpha receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is latanoprostene bunod?
latanoprostene bunod (LATANOPROSTENE BUNOD) is a prostanoid fp receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for latanoprostene bunod?
LATANOPROSTENE BUNOD is a marketed brand name for latanoprostene bunod. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of latanoprostene bunod?
latanoprostene bunod has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.